Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Posaconazole delayed-release tablets in pediatric hematology-oncology patients
Mycoses ( IF 4.1 ) Pub Date : 2020-04-15 , DOI: 10.1111/myc.13084 Margherita Mauro 1 , Antonella Colombini 2 , Katia Perruccio 3 , Daniele Zama 4 , Maria Rosaria D'Amico 5 , Elisabetta Calore 6 , Francesca Carraro 7 , Paola Muggeo 8 , Gloria Tridello 1 , Valentina Baretta 1 , Simone Cesaro 1
Mycoses ( IF 4.1 ) Pub Date : 2020-04-15 , DOI: 10.1111/myc.13084 Margherita Mauro 1 , Antonella Colombini 2 , Katia Perruccio 3 , Daniele Zama 4 , Maria Rosaria D'Amico 5 , Elisabetta Calore 6 , Francesca Carraro 7 , Paola Muggeo 8 , Gloria Tridello 1 , Valentina Baretta 1 , Simone Cesaro 1
Affiliation
To date, there are few studies that describe pharmacokinetics, safety and efficacy of posaconazole delayed‐release tablet (DRT) formulation in the paediatric population.
中文翻译：
泊沙康唑缓释片在儿科血液肿瘤患者中的应用
迄今为止，很少有研究描述泊沙康唑缓释片 (DRT) 制剂在儿科人群中的药代动力学、安全性和有效性。
更新日期：2020-04-15
中文翻译：
泊沙康唑缓释片在儿科血液肿瘤患者中的应用
迄今为止，很少有研究描述泊沙康唑缓释片 (DRT) 制剂在儿科人群中的药代动力学、安全性和有效性。
京公网安备 11010802027423号